Changes

no edit summary
Line 608: Line 608:  
|Myeloid/lymphoid neoplasm with PDGFRA rearrangement
 
|Myeloid/lymphoid neoplasm with PDGFRA rearrangement
 
|Disease
 
|Disease
|Jay Alden, DO
+
|
 
|
 
|
 
|
 
|
Line 616: Line 616:  
|
 
|
 
|
 
|
|
+
|Myeloid/Lymphoid Neoplasms with PDGFRA Rearrangement
|
+
|Jay Alden, DO
|
+
|Complete
 
|
 
|
 
|
 
|
Line 624: Line 624:  
|Myeloid/lymphoid neoplasm with PDGFRB rearrangement
 
|Myeloid/lymphoid neoplasm with PDGFRB rearrangement
 
|Disease
 
|Disease
|Christopher Sullivan, MD, MPH and Daynna J. Wolff, PhD
+
|
 
|
 
|
 
|
 
|
Line 632: Line 632:  
|
 
|
 
|
 
|
|
+
|Myeloid/Lymphoid Neoplasms with PDGFRB Rearrangement
|
+
|Christopher Sullivan, MD, MPH and Daynna J. Wolff, PhD
|
+
|Complete
 
|
 
|
 
|
 
|
Line 640: Line 640:  
|Myeloid/lymphoid neoplasm with FGFR1 rearrangement
 
|Myeloid/lymphoid neoplasm with FGFR1 rearrangement
 
|Disease
 
|Disease
|Yanna Ding, MD PhD
+
|
 
|
 
|
 
|
 
|
Line 648: Line 648:  
|
 
|
 
|
 
|
|
+
|Myeloid/Lymphoid Neoplasms with FGFR1 Rearrangement
|
+
|Yanna Ding, MD PhD
|
+
|Complete
 
|
 
|
 
|
 
|
Line 656: Line 656:  
|Myeloid/lymphoid neoplasm with JAK2 rearrangement
 
|Myeloid/lymphoid neoplasm with JAK2 rearrangement
 
|Disease
 
|Disease
|Jessica Snider, M.D. and Daynna J. Wolff, PhD
+
|
 
|
 
|
 
|
 
|
Line 664: Line 664:  
|
 
|
 
|
 
|
|
+
|Myeloid/Lymphoid Neoplasms with PCM1-JAK2 + a non-WHO page Myeloid/Lymphoid Neoplasms with ETV6-JAK2 ([[HAEM4:Myeloid/Lymphoid Neoplasms with ETV6-JAK2|Myeloid/Lymphoid Neoplasms with ETV6-JAK2 - Compendium of Cancer Genome Aberrations (ccga.io)]])  + non-WHO page Myeloid/Lymphoid Neoplasms with BCR-JAK2 ([[HAEM4:Myeloid/Lymphoid Neoplasms with BCR-JAK2|Myeloid/Lymphoid Neoplasms with BCR-JAK2 - Compendium of Cancer Genome Aberrations (ccga.io)]] )  - both non-WHO pages are authored by trainee Lauren Crowson-Hindman and Daynna Wolff
|
+
|Jessica Snider, M.D. and Daynna J. Wolff, PhD + non-WHO pages by trainee Lauren Crowson-Hindman and Daynna Wolff
|
+
|Complete
 
|
 
|
 
|
 
|